One of the most frequent questions I receive from new investors when it comes to investing in small biotech stocks is along the lines of, "Why is my stock getting hit so hard; it just recently Food and Drug Administration approval for its primary drug candidate?' Unfortunately, this happens more often than not, especially for companies where it is...
Read the full story and get access to the Real Money Pro trading floor.
There's no substitute for a trading floor to get great ideas, so Jim Cramer created a better one at Real Money and blogs there exclusively. We then added legendary hedge fund manager, Doug Kass, with his exclusive Daily Diary and best investing ideas. Staffed with more than 4 dozen investing pros, money managers, journalists and analysts, Real Money Pro gives you a flood of opinions, analysis and actionable trading advice found nowhere else, and allows you to interact directly with each expert.